ABBV
USDAbbVie Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$212.370
Haut
$217.080
Bas
$212.370
Volume
6.49M
Fondamentaux de l'Entreprise
Capitalisation Boursière
381.4B
Industrie
Drug Manufacturers - General
Pays
United States
Statistiques de Trading
Volume Moyen
5.41M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235
Citigroup analyst Geoff Meacham maintains AbbVie with a Neutral and lowers the price target from $240 to $235.
JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260
JP Morgan analyst Chris Schott maintains AbbVie with a Overweight and raises the price target from $250 to $260.
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfolio growth.
AbbVie Reports Third-Quarter 2025 Financial Results
AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2025. "AbbVie continues to deliver outstanding results, with ...
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, November...
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib...
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings
Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.